Stock Tickers: AZN, BCRX, EHTH, CTIC, HW, NRMX, SBUX, WFMI, DUK
It’s no secret we had the makings of a crummy week, but the market managed to turn itself back around after a fairly week open. Regardles of a bull market or any market, there are still stocks hitting 52-week lows:
AstraZeneca (AZN) ADR’s put in lows, two days after the CFO left to join Goldman Sachs.
BioCryst (BCRX) stays weak, apparently the near-term bounce turned back into a pounce.
Cell Therapeutics (CTIC) managed to keep its post-ASCO slide going.
eHealth, Inc (EHTH) put in the lowest close since its October IPO.
Headwaters (HW) just keeps slipping and looks uglier daily, and has been oin a crash course for about 6 weeks..
Neurochem (NRMX) closed down another 10% after the poor drug outlook yesterday.
Starbucks (SBUX) and Whole Foods (WFMI) were in the 52-week low gutter club earlier but got bailed out by the market offer. Duke Energy (DUK) also rode most of the day on new adjusted lows before an end of day recovery, although these might not be ultimate 52-week lows on an adjusted basis.
Jon C. Ogg
June 8, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
